Dr. Natasha Szuber is a hematologist-oncologist and clinician-scientist working at the Maisonneuve-Rosemont Hospital.

After completing her M.Sc. in Physiology at McGill University, she pursued her Medical and Hematology-Oncology training at the University of Montreal. She then completed her fellowship in myeloid disorders at the Mayo Clinic in 2018. Her main clinical and research focus is on myeloproliferative neoplasms (MPN) and disease mimickers, such as secondary erythrocytosis. She is interested in large-scale epidemiological studies as well as applied and translational aspects of genomics, with the ultimate goal of improving patient care. She is an active executive member of both the Groupe québécois de recherche LMC-NMP and the Canadian MPN Group.